• Info
  • Significant Ownership

Significant Ownership of Bonita Biotech (HK) Ltd

Signature - Title
/s/ MINGJIU CHEN - MINGJIU CHEN / Director
Location
Wan Chai
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Bonita Biotech (HK) Ltd.

Notify me when Bonita Biotech (HK) Ltd files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of Bonita Biotech (HK) Ltd

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ACRS Aclaris Therapeutics, Inc. Common Stock, $0.00001 par value 9.4% $33,944,003 11,281,950 Biosion, Inc. 09 Dec 2025

Schedules 13D/G Reported by Bonita Biotech (HK) Ltd:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.